{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:24:31Z","timestamp":1780345471570,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.cancergencyto.2005.02.015","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:35:40Z","timestamp":1124019340000},"page":"116-124","source":"Crossref","is-referenced-by-count":20,"title":["High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH"],"prefix":"10.1016","volume":"161","author":[{"given":"Friedrich W.","family":"Cremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutlu","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Bila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Bellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Steffen","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Brough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Moebus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus R.","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.02.015_bib1","first-page":"2109","article-title":"Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma","volume":"9","author":"Flactif","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.2001.02546.x","article-title":"Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma","volume":"112","author":"Sawyer","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/mp.55.5.273","article-title":"Molecular aspects of multiple myeloma","volume":"55","author":"Pratt","year":"2002","journal-title":"Mol Pathol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0959-8049(93)90071-M","article-title":"Karyotype in multiple myeloma and plasma cell leukaemia","volume":"29A","author":"Weh","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1365-2141.2003.04221.x","article-title":"A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences","volume":"120","author":"Nilsson","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib7","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1073\/pnas.93.21.11837","article-title":"Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders","volume":"93","author":"Stilgenbauer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-065X.2003.00052.x","article-title":"Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma","volume":"194","author":"Bergsagel","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0","article-title":"Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization","volume":"19","author":"Avet-Loiseau","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib10","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V91.8.3007.3007_3007_3010","article-title":"Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization","volume":"91","author":"Cigudosa","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.leu.2402116","article-title":"Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization","volume":"15","author":"Gutierrez","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2141.2003.04417.x","article-title":"Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma","volume":"122","author":"Liebisch","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib13","first-page":"153","article-title":"Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes","volume":"149","author":"Tabernero","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.2000.18.4.804","article-title":"Predictive role of interphase cytogenetics for survival of patients with multiple myeloma","volume":"18","author":"K\u00f6nigsberg","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib15","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/sj.leu.2403153","article-title":"High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis","volume":"17","author":"Liebisch","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib16","first-page":"1213","article-title":"The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma","volume":"89","author":"Gonzalez","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib17","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14) (p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib18","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","article-title":"Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients","volume":"99","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","article-title":"Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy","volume":"100","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib20","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","article-title":"Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities","volume":"86","author":"Tricot","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib21","first-page":"1146","article-title":"Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells","volume":"85","author":"Gutierrez","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood-2002-12-3789","article-title":"Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation","volume":"102","author":"Soverini","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib23","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2004-04-1319","article-title":"Prognostic and biological significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma","volume":"104","author":"Gutierrez","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2141.2000.02007.x","article-title":"Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance","volume":"109","author":"Hoechtlen-Vollmar","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib25","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood-2003-11-3837","article-title":"Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels","volume":"104","author":"Specht","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib26","series-title":"Human cytogenetics","first-page":"157","article-title":"Chromosome analysis by non-isotopic in situ hybridization","author":"Lichter","year":"1992"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","article-title":"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation","volume":"102","author":"Blade","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2307\/1390807","article-title":"A language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comput Graph Stat"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1003>3.3.CO;2-L","article-title":"MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23","volume":"29","author":"Michaux","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib30","first-page":"55","article-title":"Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics","volume":"58","author":"Caligiuri","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib31","first-page":"377","article-title":"Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32)","volume":"54","author":"Akiyama","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1097-2765(00)80180-X","article-title":"Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell","volume":"3","author":"Gabrea","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib33","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/j.1460-2075.1992.tb05332.x","article-title":"Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification","volume":"11","author":"Toledo","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/gcc.10275","article-title":"Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases","volume":"38","author":"Smadja","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib35","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"Shaughnessy","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.02.015_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2141.2002.03231.x","article-title":"Predicting long-term (\u22655 years) event-free survival in multiple myeloma patients following planned tandem autotransplants","volume":"116","author":"Tricot","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:52:41Z","timestamp":1586393561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0165460805001160"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.02.015","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}